Page last updated: 2024-10-15

pteroic acid

Description

pteroic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135398749
CHEMBL ID341824
CHEBI ID37066
CHEBI ID27623
CHEBI ID37055
SCHEMBL ID245980
MeSH IDM0047233

Synonyms (69)

Synonym
4-{[(2-amino-4-hydroxypteridin-6-yl)methyl]amino}benzoic acid
chembl341824 ,
pteridine deriv. 12
bdbm6645
p-((2-amino-4-hydroxy-6-pteridylmethyl)amino)benzoic acid
4-((2-amino-4-hydroxy-6-pteridylmethyl)amino)benzoic acid
CHEBI:37066
4-{[(2-amino-3,4-dihydro-4-oxopteridin-6-yl)methyl]amino}benzoic acid
4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoic acid
CHEBI:27623 ,
CHEBI:37055
4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoic acid
nsc-14972
benzoic acid,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]-
nsc14972
pteroic acid
119-24-4
C07582
DB04196
1BR6
pteroic acid, >=93%
peroic acid
4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoic acid
pyrofolic acid
4-[(2-amino-4-oxo-1h-pteridin-6-yl)methylamino]benzoic acid
78h ,
8258w48tbz ,
benzoic acid, 4-(((2-amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)-
nsc 14972
unii-8258w48tbz
AKOS015995562
AKOS016009238
FT-0674151
4-(((2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl)amino)benzoic acid
benzoic acid, 4-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)-
folic acid hydrate impurity d [ep impurity]
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid
4-(((2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoic acid
pteroic acid [mi]
AM20120647
c14h12n6o3
SCHEMBL245980
CS-M2878
4-[(2-amino-4-oxo-3,4-dihydropteridin-6-ylmethyl)-amino]-benzoic acid
4-([(2-amino-4-oxo-3,4-dihydro-6-pteridinyl)methyl]amino)benzoic acid #
benzoic acid, p-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]-
DTXSID40152279
mfcd00075823
pterotic acid
J-004089
SR-01000883746-1
sr-01000883746
folic acid impurity d, european pharmacopoeia (ep) reference standard
folic acid impurity d, pharmaceutical secondary standard; certified reference material
DS-3903
BCP04836
SY058064
EX-A2652
4-((2-amino-4-hydroxypteridin-6-yl)methylamino)benzoic acid
Q27095023
22D ,
pteroic?acid
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid (pteroic acid)
4-[[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino]benzoic acid; folic acid imp. d (ep); pteroic acid; folic acid hydrate impurity d; folic acid impurity d
4-[[(2-amino-4-oxo-1,4 dihydropteridin-6-yl)methyl]amino]benzoic acid
4-[(2-amino-4-oxo-3h-pteridin-6-yl)methylamino]benzoic acid
EN300-109015
pteroic acid (>85per cent)
folic acid impurity d
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
pteroic acid
pteroic acid
pteroic acid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (5)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Protein (ricin)Ricinus communis (castor bean)Ki600.0000600.0000600.0000600.0000AID977610
Chain A, Protein (ricin)Ricinus communis (castor bean)Ki600.0000600.0000600.0000600.0000AID977610
Cyclin-dependent kinase 4Homo sapiens (human)IC50 (µMol)16.00000.00060.570610.0000AID1795925
G1/S-specific cyclin-D1Homo sapiens (human)IC50 (µMol)16.00000.00060.54799.5000AID1795925
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (39)

Processvia Protein(s)Taxonomy
G1/S transition of mitotic cell cycleCyclin-dependent kinase 4Homo sapiens (human)
protein phosphorylationCyclin-dependent kinase 4Homo sapiens (human)
positive regulation of cell population proliferationCyclin-dependent kinase 4Homo sapiens (human)
response to xenobiotic stimulusCyclin-dependent kinase 4Homo sapiens (human)
regulation of gene expressionCyclin-dependent kinase 4Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 4Homo sapiens (human)
positive regulation of fibroblast proliferationCyclin-dependent kinase 4Homo sapiens (human)
cell divisionCyclin-dependent kinase 4Homo sapiens (human)
regulation of cell cycleCyclin-dependent kinase 4Homo sapiens (human)
regulation of transcription initiation by RNA polymerase IICyclin-dependent kinase 4Homo sapiens (human)
regulation of type B pancreatic cell proliferationCyclin-dependent kinase 4Homo sapiens (human)
cellular response to lipopolysaccharideCyclin-dependent kinase 4Homo sapiens (human)
cellular response to interleukin-4Cyclin-dependent kinase 4Homo sapiens (human)
cellular response to phorbol 13-acetate 12-myristateCyclin-dependent kinase 4Homo sapiens (human)
cellular response to ionomycinCyclin-dependent kinase 4Homo sapiens (human)
response to organic substanceCyclin-dependent kinase 4Homo sapiens (human)
regulation of G2/M transition of mitotic cell cycleCyclin-dependent kinase 4Homo sapiens (human)
signal transductionCyclin-dependent kinase 4Homo sapiens (human)
G1/S transition of mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIG1/S-specific cyclin-D1Homo sapiens (human)
re-entry into mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of protein phosphorylationG1/S-specific cyclin-D1Homo sapiens (human)
DNA damage responseG1/S-specific cyclin-D1Homo sapiens (human)
lactationG1/S-specific cyclin-D1Homo sapiens (human)
response to xenobiotic stimulusG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of G2/M transition of mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
Wnt signaling pathwayG1/S-specific cyclin-D1Homo sapiens (human)
neuron differentiationG1/S-specific cyclin-D1Homo sapiens (human)
negative regulation of epithelial cell differentiationG1/S-specific cyclin-D1Homo sapiens (human)
endoplasmic reticulum unfolded protein responseG1/S-specific cyclin-D1Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingG1/S-specific cyclin-D1Homo sapiens (human)
mammary gland epithelial cell proliferationG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of mammary gland epithelial cell proliferationG1/S-specific cyclin-D1Homo sapiens (human)
negative regulation of neuron apoptotic processG1/S-specific cyclin-D1Homo sapiens (human)
response to leptinG1/S-specific cyclin-D1Homo sapiens (human)
fat cell differentiationG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of cyclin-dependent protein serine/threonine kinase activityG1/S-specific cyclin-D1Homo sapiens (human)
cell divisionG1/S-specific cyclin-D1Homo sapiens (human)
mammary gland alveolus developmentG1/S-specific cyclin-D1Homo sapiens (human)
response to UV-AG1/S-specific cyclin-D1Homo sapiens (human)
liver regenerationG1/S-specific cyclin-D1Homo sapiens (human)
positive regulation of G1/S transition of mitotic cell cycleG1/S-specific cyclin-D1Homo sapiens (human)
regulation of cyclin-dependent protein serine/threonine kinase activityG1/S-specific cyclin-D1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (13)

Processvia Protein(s)Taxonomy
cyclin-dependent protein serine/threonine kinase activityCyclin-dependent kinase 4Homo sapiens (human)
protein bindingCyclin-dependent kinase 4Homo sapiens (human)
ATP bindingCyclin-dependent kinase 4Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityCyclin-dependent kinase 4Homo sapiens (human)
cyclin bindingCyclin-dependent kinase 4Homo sapiens (human)
protein serine kinase activityCyclin-dependent kinase 4Homo sapiens (human)
transcription corepressor activityG1/S-specific cyclin-D1Homo sapiens (human)
protein kinase activityG1/S-specific cyclin-D1Homo sapiens (human)
protein bindingG1/S-specific cyclin-D1Homo sapiens (human)
enzyme bindingG1/S-specific cyclin-D1Homo sapiens (human)
protein kinase bindingG1/S-specific cyclin-D1Homo sapiens (human)
histone deacetylase bindingG1/S-specific cyclin-D1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase activator activityG1/S-specific cyclin-D1Homo sapiens (human)
proline-rich region bindingG1/S-specific cyclin-D1Homo sapiens (human)
cyclin-dependent protein serine/threonine kinase regulator activityG1/S-specific cyclin-D1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (16)

Processvia Protein(s)Taxonomy
nucleusCyclin-dependent kinase 4Homo sapiens (human)
nucleoplasmCyclin-dependent kinase 4Homo sapiens (human)
nucleolusCyclin-dependent kinase 4Homo sapiens (human)
cytosolCyclin-dependent kinase 4Homo sapiens (human)
bicellular tight junctionCyclin-dependent kinase 4Homo sapiens (human)
nuclear membraneCyclin-dependent kinase 4Homo sapiens (human)
cyclin D1-CDK4 complexCyclin-dependent kinase 4Homo sapiens (human)
cyclin D2-CDK4 complexCyclin-dependent kinase 4Homo sapiens (human)
cyclin D3-CDK4 complexCyclin-dependent kinase 4Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexCyclin-dependent kinase 4Homo sapiens (human)
chromatinCyclin-dependent kinase 4Homo sapiens (human)
transcription regulator complexCyclin-dependent kinase 4Homo sapiens (human)
nucleusCyclin-dependent kinase 4Homo sapiens (human)
cytoplasmCyclin-dependent kinase 4Homo sapiens (human)
nucleusG1/S-specific cyclin-D1Homo sapiens (human)
nucleoplasmG1/S-specific cyclin-D1Homo sapiens (human)
cytosolG1/S-specific cyclin-D1Homo sapiens (human)
bicellular tight junctionG1/S-specific cyclin-D1Homo sapiens (human)
nuclear membraneG1/S-specific cyclin-D1Homo sapiens (human)
cyclin D1-CDK4 complexG1/S-specific cyclin-D1Homo sapiens (human)
cyclin D1-CDK6 complexG1/S-specific cyclin-D1Homo sapiens (human)
cyclin-dependent protein kinase holoenzyme complexG1/S-specific cyclin-D1Homo sapiens (human)
transcription repressor complexG1/S-specific cyclin-D1Homo sapiens (human)
centrosomeG1/S-specific cyclin-D1Homo sapiens (human)
cytoplasmG1/S-specific cyclin-D1Homo sapiens (human)
nucleusG1/S-specific cyclin-D1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID1811Experimentally measured binding affinity data derived from PDB1997Journal of molecular biology, Mar-14, Volume: 266, Issue:5
Structure-based identification of a ricin inhibitor.
AID977610Experimentally measured binding affinity data (Ki) for protein-ligand complexes derived from PDB1997Journal of molecular biology, Mar-14, Volume: 266, Issue:5
Structure-based identification of a ricin inhibitor.
AID66419Inhibitory concentration against Enzymatic A chain of ricin (RTA) using Artemia salina ribosomes2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition.
AID722426Inhibition of Ricin toxin A2013Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
Peptide-conjugated pterins as inhibitors of ricin toxin A.
AID614830Inhibition of castor seed ricin A chain translation degradation activity in rabbit reticulocyte lysate after 90 mins by luciferase-based luminometer analysis2011European journal of medicinal chemistry, Sep, Volume: 46, Issue:9
7-Substituted pterins provide a new direction for ricin A chain inhibitors.
AID1146785Induction of Streptococcus faecalis growth1977Journal of medicinal chemistry, Mar, Volume: 20, Issue:3
P-Aminobenzoic acid derivatives. Mode of action and structure-activity relationships in a cell-free system (Escherichia coli).
AID203036Concentration required for 50% inhibition of Shiga-like toxin type 1 (Stx1A1)2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Structure-based design and characterization of novel platforms for ricin and shiga toxin inhibition.
AID220180Inhibitory activity against CDK4 using recombinant human cyclin D2-CDK4 complex expressed in sf9 cells2001Journal of medicinal chemistry, Dec-20, Volume: 44, Issue:26
Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design.
AID1795925CDKs Assay from Article 10.1021/jm0103256: \\Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design.\\2001Journal of medicinal chemistry, Dec-20, Volume: 44, Issue:26
Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (36)

TimeframeStudies, This Drug (%)All Drugs %
pre-199018 (50.00)18.7374
1990's4 (11.11)18.2507
2000's7 (19.44)29.6817
2010's7 (19.44)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other36 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]